Incretin-based diabetes therapies (GLP-1 receptor agonists and DPP-4 inhibitors)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Incretin-based diabetes therapies (GLP-1 receptor agonists and DPP-4 inhibitors), covering 2016-03-14 to 2016-03-14. Get the full timeline:
Most recent: Clinical Trial Update: Incretin-based Drugs and Pancreatic Cancer